Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McClellan on inpatient rule

This article was originally published in The Gray Sheet

Executive Summary

"We are acutely aware of the disruptions that could occur if major changes are made too quickly or inappropriately," writes CMS Administrator Mark McClellan in a July 20 letter to Sen. Rick Santorum (R-Pa.). He notes that the final inpatient payment system rule, due out Aug. 1, "will reflect modifications as appropriate to achieve the goal of smooth and effective implementation." The letter is in response to comments signed by 53 senators and 189 representatives urging a one-year delay to proposed changes to the system that would switch to cost-based payments and adjust diagnosis-related groups for illness severity (1"The Gray Sheet" July 17, 2006, p. 6)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023803

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel